Avinash Maganty

493 total citations
54 papers, 312 citations indexed

About

Avinash Maganty is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Economics and Econometrics. According to data from OpenAlex, Avinash Maganty has authored 54 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 18 papers in Surgery and 17 papers in Economics and Econometrics. Recurrent topics in Avinash Maganty's work include Prostate Cancer Diagnosis and Treatment (18 papers), Healthcare Policy and Management (10 papers) and Prostate Cancer Treatment and Research (10 papers). Avinash Maganty is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (18 papers), Healthcare Policy and Management (10 papers) and Prostate Cancer Treatment and Research (10 papers). Avinash Maganty collaborates with scholars based in United States, Australia and Italy. Avinash Maganty's co-authors include Jathin Bandari, Benjamin J. Davies, Bruce L. Jacobs, Liam C. Macleod, Ranjith Ramasamy, E. Charles Osterberg, J. François Eid, Jonathan G. Yabes, Katherine Theisen and Ben Davies and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer.

In The Last Decade

Avinash Maganty

45 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Avinash Maganty United States 10 122 78 62 49 45 54 312
Bridget L. Findlay United States 8 72 0.6× 112 1.4× 34 0.5× 17 0.3× 63 1.4× 29 254
Alexandra L. Tabakin United States 12 105 0.9× 86 1.1× 35 0.6× 16 0.3× 77 1.7× 48 319
Ömer Yılmaz Türkiye 9 99 0.8× 76 1.0× 37 0.6× 6 0.1× 38 0.8× 54 291
Daniel S. Murtagh United States 8 108 0.9× 63 0.8× 161 2.6× 38 0.8× 49 1.1× 11 352
M Eng Ireland 9 184 1.5× 57 0.7× 16 0.3× 8 0.2× 38 0.8× 17 332
Mina Fam United States 10 152 1.2× 83 1.1× 74 1.2× 8 0.2× 39 0.9× 24 263
Molly Dewitt‐Foy United States 10 57 0.5× 161 2.1× 54 0.9× 7 0.1× 16 0.4× 40 279
Francesco Chierigo Italy 16 210 1.7× 276 3.5× 161 2.6× 12 0.2× 40 0.9× 84 740
Edoardo La Sala Italy 10 130 1.1× 34 0.4× 28 0.5× 10 0.2× 30 0.7× 21 301
Rufus Wale Ojewola Nigeria 12 107 0.9× 148 1.9× 115 1.9× 7 0.1× 47 1.0× 56 355

Countries citing papers authored by Avinash Maganty

Since Specialization
Citations

This map shows the geographic impact of Avinash Maganty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avinash Maganty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avinash Maganty more than expected).

Fields of papers citing papers by Avinash Maganty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avinash Maganty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avinash Maganty. The network helps show where Avinash Maganty may publish in the future.

Co-authorship network of co-authors of Avinash Maganty

This figure shows the co-authorship network connecting the top 25 collaborators of Avinash Maganty. A scholar is included among the top collaborators of Avinash Maganty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avinash Maganty. Avinash Maganty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maganty, Avinash, et al.. (2025). Surgery at High-Quality Hospitals Among Medicare Advantage Beneficiaries Undergoing Cancer Surgery. JAMA Surgery. 160(12). 1341–1341.
2.
Kaufman, Samuel R., Mary Oerline, Xiu Liu, et al.. (2025). Physician Payment Incentives and Active Surveillance in Low-Risk Prostate Cancer. JAMA Network Open. 8(1). e2453658–e2453658.
3.
Srivastava, Arnav, Xiu Liu, Avinash Maganty, et al.. (2024). Commercial prices and their influence on urology practices: Prostate cancer care among men with Medicare. Cancer. 131(1). e35633–e35633.
4.
Maganty, Avinash, et al.. (2024). Association of Community-Level Social Vulnerability With Clinical Trial Discussion and Participation Among Cancer Survivors. JCO Oncology Practice. 21(2). 235–244. 3 indexed citations
5.
6.
7.
Kaufman, Samuel R., Lindsey A. Herrel, Avinash Maganty, et al.. (2023). The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer. Cancer Medicine. 12(24). 22325–22332. 1 indexed citations
8.
Maganty, Avinash, Samuel R. Kaufman, Mary Oerline, et al.. (2023). Value‐based payment models and management of newly diagnosed prostate cancer. Cancer Medicine. 13(1). e6810–e6810. 2 indexed citations
9.
Kaufman, Samuel R., Mary Oerline, Megan E.V. Caram, et al.. (2023). In-office dispensing of oral targeted agents by urology practices in men with advanced prostate cancer. JNCI Cancer Spectrum. 7(5).
10.
Maganty, Avinash, et al.. (2023). Financial Implications of the Merit-Based Incentive Payment System for Surgical Health Care Professionals. JAMA Surgery. 159(2). 221–221. 1 indexed citations
11.
Kaufman, Samuel R., Lindsey A. Herrel, Avinash Maganty, et al.. (2023). Acquisition of Urology Practices by Private Equity Firms and Performance in the Merit-based Incentive Payment System. Urology Practice. 10(6). 597–603.
12.
Maganty, Avinash & Brent K. Hollenbeck. (2023). New technology in prostate cancer and financial toxicity. Urologic Oncology Seminars and Original Investigations. 41(9). 376–379. 1 indexed citations
13.
Kaufman, Samuel R., Lindsey A. Herrel, Mary Oerline, et al.. (2023). Association between urology practice use of multiparametric MRI and genomic testing and treatment of men with newly diagnosed prostate cancer. Urologic Oncology Seminars and Original Investigations. 41(10). 430.e17–430.e23. 1 indexed citations
14.
Kaufman, Samuel R., Mary Oerline, Megan E.V. Caram, et al.. (2023). Health care delivery system contributions to management of newly diagnosed prostate cancer. Cancer Medicine. 12(16). 17346–17355. 4 indexed citations
15.
16.
Jacobs, Bruce L., Devin Rogers, Jonathan G. Yabes, et al.. (2020). Large reduction in opioid prescribing by a multipronged behavioral intervention after major urologic surgery. Cancer. 127(2). 257–265. 20 indexed citations
17.
Macleod, Liam C., Jonathan G. Yabes, Mina Fam, et al.. (2019). Multiparametric Magnetic Resonance Imaging Is Associated with Increased Medicare Spending in Prostate Cancer Active Surveillance. European Urology Focus. 6(2). 242–248. 4 indexed citations
18.
Bandari, Jathin, Avinash Maganty, Liam C. Macleod, & Benjamin J. Davies. (2018). Manufacturing and the Market: Rationalizing the Shortage of Bacillus Calmette-Guérin. European Urology Focus. 4(4). 481–484. 36 indexed citations
19.
Osterberg, E. Charles, Michael Schulster, Jerry G. Blaivas, et al.. (2016). Urethroplasty Improves Overactive Bladder Symptoms in Men With Anterior Urethral Strictures. Urology. 93. 208–212. 7 indexed citations
20.
Osterberg, E. Charles, Avinash Maganty, Ranjith Ramasamy, & J. François Eid. (2014). Pharmacologically induced erect penile length and stretched penile lengh are both good predictors of post-inflatable prosthesis penile length. International Journal of Impotence Research. 26(4). 128–131. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bridget L. Findlay Breakdown of academic impact, for papers by Alexandra L. Tabakin Breakdown of academic impact, for papers by Ömer Yılmaz Breakdown of academic impact, for papers by Daniel S. Murtagh Breakdown of academic impact, for papers by M Eng Breakdown of academic impact, for papers by Mina Fam Breakdown of academic impact, for papers by Molly Dewitt‐Foy Breakdown of academic impact, for papers by Francesco Chierigo Breakdown of academic impact, for papers by Edoardo La Sala Breakdown of academic impact, for papers by Rufus Wale Ojewola
Rankless by CCL
2026